Christiaans M - Search Results

1

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.

Mayer AD, Dmitrewski J, Squifflet JP, Besse T, Grabensee B, Klein B, Eigler FW, Heemann U, Pichlmayr R, Behrend M, Vanrenterghem Y, Donck J, van Hooff J, Christiaans M, Morales JM, Andres A, Johnson RW, Short C, Buchholz B, Rehmert N, Land W, Schleibner S, Forsythe JL, Talbot D, Pohanka E, et al. Mayer AD, et al. Among authors: christiaans m. Transplantation. 1997 Aug 15;64(3):436-43. doi: 10.1097/00007890-199708150-00012. Transplantation. 1997. PMID: 9275110 Clinical Trial.

2

Very low frequency of rejection due to HLA-(A+)B+DQ matching.

Christiaans MH, van den Berg-Loonen PM, Nieman FH, van Hooff JP. Christiaans MH, et al. Transplant Proc. 1992 Dec;24(6):2441-2. Transplant Proc. 1992. PMID: 1465822 No abstract available.

3

More favorable clinical course in kidney allograft recipients due to HLA-B+ DR matching.

Christiaans MH, van den Berg-Loonen PM, Peltenburg HG, Leunissen KM, van Hooff JP. Christiaans MH, et al. Transplant Proc. 1991 Oct;23(5):2674. Transplant Proc. 1991. PMID: 1926529 Clinical Trial. No abstract available.

4

Influence of ACE inhibition on haemoglobin and haematocrit in essential hypertensive patients.

Spiering W, Christiaans MH, de Leeuw PW, van Hooff JP. Spiering W, et al. Among authors: christiaans mh. Nephrol Dial Transplant. 1995;10(7):1254. Nephrol Dial Transplant. 1995. PMID: 7478137 No abstract available.

5

FK 506 versus cyclosporin in the prevention of renal allograft rejection--European pilot study: six-week results.

Schleibner S, Krauss M, Wagner K, Erhard J, Christiaans M, van Hooff J, Buist L, Mayer D. Schleibner S, et al. Among authors: christiaans m. Transpl Int. 1995;8(2):86-90. doi: 10.1007/BF00344416. Transpl Int. 1995. PMID: 7539270 Clinical Trial.

6

Renal graft thrombosis.

Peek D, Kootstra G, Christiaans MH, van Hooff JP. Peek D, et al. Among authors: christiaans mh. Transplantation. 1995 Aug 15;60(3):311. Transplantation. 1995. PMID: 7645047 No abstract available.

7

Effect of flow cytometry, complement-dependent cytotoxicity, and auto cross match on cadaveric renal transplant outcome.

Christiaans M, Van den Berg-Loonen E, Ten Haaft A, Nieman F, Van Hooff J. Christiaans M, et al. Transplant Proc. 1995 Feb;27(1):1028-30. Transplant Proc. 1995. PMID: 7878788 No abstract available.

8

Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy.

Kraat YJ, Christiaans MH, Nieman FH, van den Berg-Loonen PM, van Hooff JP, Bruggeman CA. Kraat YJ, et al. Among authors: christiaans mh. Transpl Int. 1994 Aug;7(5):362-7. doi: 10.1007/BF00336713. Transpl Int. 1994. PMID: 7993574

9

Cadaveric kidney exchange on the basis of HLA-matching is already cost-effective in the first year after grafting.

Christiaans MH, van den Berg-Loonen PM, Nieman FH, Cohen B, Kootstra G, van Hooff JP. Christiaans MH, et al. Transplant Proc. 1993 Feb;25(1 Pt 2):1685-6. Transplant Proc. 1993. PMID: 8442236 No abstract available.

10

No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients.

Christiaans MH, Overhof R, ten Haaft A, Nieman F, van Hooff JP, van den Berg-Loonen EM. Christiaans MH, et al. Transplantation. 1996 Nov 15;62(9):1341-7. doi: 10.1097/00007890-199611150-00028. Transplantation. 1996. PMID: 8932282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page